Delivery Order SPE2DB20D2104-SPE2DB24FU83S

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,093.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567873449 - APREPITANT 40 MG CAPSULE UD 5S, and has a firm fixed price pricing type with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,464.58 firm fixed-price contract is for the delivery of APREPITANT 80 MG CAPSULE UD 6S, a specialty pharmaceutical product, with a completion date of October 23, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $7,008.15, with a Firm Fixed Price pricing type. The award is for the provision of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract has an Ultimate Completion Date of June 12, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award, which is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,373.82 firm-fixed-price delivery order is for the supply of APREPITANT 40 MG CAPSULE UDS medical products. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,517.22 firm-fixed-price delivery order is for the supply of 4562584778 APREPITANT 40 MG CAPSULE UD 5S, with an ultimate completion date of October 25, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Aprepitant 40 mg capsules. The Delivery Order, valued at $5,369.62, has a firm fixed price and an ultimate completion date of July 24, 2024. Amerisourcebergen is the prime contractor and there is no set-aside designation noted. The contract is likely part of a larger Indefinite Delivery Contract (IDC) vehicle held by...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of 4556527817 APREPITANT 80 MG CAPSULE UU 2S to the Defense Logistics Agency (DLA). The $3,531.50 firm fixed-price contract has a completion date of March 11, 2022. This delivery order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,785.12, is for the delivery of APREPITANT 125 MG CAPSULE UD 6S, a prescription medication. The contract is a firm fixed-price, indefinite delivery vehicle with a performance period through November 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen is the...
This federal contract award, with an ID of SPE2DB22D1106 and SPE2DB24FEWZ0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a medication, with a ceiling value of $4,389.28 and a completion date of June 14, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract, valued at up to $18,539.00, is a Delivery Order for the supply of Aprepitant 80 mg capsules. The contract has a period of performance ending on April 23, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU83S
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of APREPITANT 40 MG CAPSULE UDS. The contract is a Delivery Order with a Firm Fixed Price of $1,984.41 and a period of performance through June 25, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, on June 24, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, both of which cover a range of pharmaceutical and medical supply products to support federal healthcare programs.

Generated 2/27/25, 11:37 AM